IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re application of:
`
`ATWAL et al.
`
`Appl. No.: 11/797,082
`
`Filed: April 30, 2007
`
`Confirmation No.2 2828
`
`Art Unit: 1617
`
`Examiner: Chong, Yong Soo
`
`Atty. Docket: 2305.0330001/TJS/ASL
`
`For: Triaryl Substituted Imidazole Derivatives
`and Taste-Inhibiting Uses Thereof
`
`Information Disclosure Statement
`
`Commissioner for Patents
`PO Box 1450
`
`Alexandria, VA 22313-1450
`
`Sir:
`
`Mail Stop Amendment
`
`Listed on accompanying IDS Forms PTO/SB/OSA and PTO/SB/OSB are
`
`documents that may be considered material to the examination of this application, in
`
`compliance with the duty of disclosure requirements of 37 C.F.R. §§ 1.56, 1.97 and 1.98.
`
`Copies of documents FPl, NPLl and NPLZ are submitted. However,
`
`in
`
`accordance with 37 CPR. § 1.98(a)(2), no copies of US. patents and patent application
`
`publications cited on the attached lDS Forms are submitted.
`
`Where the publication date of a listed document does not provide a month of
`
`publication, the year of publication of the listed document is sufficiently earlier than the
`
`effective U.S. filing date and any foreign priority date so that the month of publication is
`
`not
`
`in issue. Applicants have listed publication dates on the attached IDS Forms
`
`PTO/SB/OSA and PTO/SB/08B based on information presently available to the
`
`undersigned. However,
`
`the listed publication dates should not be construed as an
`
`admission that the information was actually published on the date indicated.
`
`
`
`— 2 —
`
`ATWAL et al.
`
`Appl. No. 11/797,082
`
`Applicants reserve the right to establish the patentability of the claimed invention
`
`over any of the information provided herewith, and/or to prove that this information may
`
`not be prior art, and/or to prove that this information may not be enabling for the
`
`teachings purportedly offered.
`
`This statement should not be construed as a representation that a search has been
`
`made, or that
`
`information more material
`
`to the examination of the present patent
`
`application does not exist. The Examiner is specifically requested not to rely solely on
`
`the material submitted herewith.
`
`This Information Disclosure Statement is being filed before the mailing date of a
`
`first Office Action on the merits. No statement or fee is required.
`
`It is respectfully requested that the Examiner initial and return a copy of the
`
`enclosed IDS Forms PTO/SB/OSA and PTO/SB/08B, and indicate in the official file
`
`wrapper of this patent application that the documents have been considered.
`
`The US. Patent and Trademark Office is hereby authorized to charge any fee
`
`deficiency, or credit any overpayment, to our Deposit Account No. 19-0036.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`Aaron S. Lukas
`
`Agent for Applicants
`Registration No. 59,443
`
`766635__1.DOC
`
`Atty. Dkt. N0. 2305.0330001/TJS/ASL
`
`Janufl 11, 2008
`Date:
`1100 New York Avenue, NW.
`Washington, DC. 20005 -3934
`(202) 371 -2600
`
`
